PREZIOSO, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 744
EU - Europa 614
AS - Asia 284
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
OC - Oceania 1
Totale 1.648
Nazione #
US - Stati Uniti d'America 733
CN - Cina 239
IE - Irlanda 143
SE - Svezia 140
FI - Finlandia 125
IT - Italia 97
DE - Germania 48
UA - Ucraina 31
TR - Turchia 27
FR - Francia 14
CA - Canada 11
SG - Singapore 10
BE - Belgio 7
IN - India 6
RO - Romania 6
EU - Europa 4
CZ - Repubblica Ceca 1
GB - Regno Unito 1
IR - Iran 1
JP - Giappone 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 1.648
Città #
Dublin 143
Chandler 113
Dearborn 98
Jacksonville 59
Ashburn 50
Parma 44
Ann Arbor 43
Beijing 42
New York 40
Nanjing 36
Wilmington 31
Izmir 26
Princeton 22
Boardman 20
Shanghai 19
Jinan 18
Seattle 17
Nanchang 16
San Mateo 16
Bremen 13
Shenyang 11
Helsinki 10
Toronto 10
Changsha 8
Des Moines 8
Hebei 8
Hefei 8
Tulsa 8
Brussels 7
Jiaxing 7
Kunming 7
Hangzhou 6
Los Angeles 6
Norwalk 6
Pune 6
Tianjin 6
Woodbridge 6
Lanzhou 5
Focsani 4
Fremont 4
Rome 4
Haikou 3
Houston 3
Taiyuan 3
Taizhou 3
Fuzhou 2
Genova 2
Harbin 2
Mestre 2
Ningbo 2
Pinerolo 2
Timisoara 2
West Jordan 2
Xian 2
Zhengzhou 2
Ardabil 1
Baotou 1
Borås 1
Botticino 1
Caselette 1
Changchun 1
Chongqing 1
Codroipo 1
Düsseldorf 1
Guangzhou 1
Kocaeli 1
Lagos 1
Miami 1
Milton Keynes 1
Modena 1
Montréal 1
Napoli 1
Old Bridge 1
Padova 1
Paris 1
Pinehaven 1
Rho 1
Scottsdale 1
Shaoxing 1
Tappahannock 1
Torino 1
Torre Annunziata 1
Velletri 1
Walnut 1
Washington 1
Zhongxin 1
Totale 1.074
Nome #
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 118
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 117
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 102
Diabetes impairs hematopoietic stem cell mobilization by altering niche function 100
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 95
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 93
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 88
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 83
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 80
Studio in vitro ed in vivo della biocompatibilità di PAM (pharmacologically active microcarriers) come substrato per la rigenerazione miocardica 77
Imatinib mesylate induced cardiotoxicity: a cardiac progenitor cell disease? 73
Stem cells and myocardial regeneration 72
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 69
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 66
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 65
Diabetes mellitus induces bone marrow microangiopathy 61
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 60
BORTEZOMIB WITH HIGH DOSE MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND IMPROVES THE RESPONSE RATE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA 53
Doxorubicin induces senescence and impairs function of human cardiac progenitor cells 52
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 46
BORTEZOMIB IN COMBINATION WITH HIGH DOSE MELPHALAN AS CONDITIONING REGIMEN IS SAFE AND IMPROVES THE RESPONSE RATES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA 45
Noncanonical Fungal Autophagy Inhibits Inflammation in Response to IFN-γ via DAPK1 42
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 5
Totale 1.662
Categoria #
all - tutte 4.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 35 4
2019/2020390 58 55 20 15 30 72 49 9 28 35 5 14
2020/2021124 2 13 5 3 18 3 13 9 36 7 14 1
2021/2022105 4 1 0 9 3 0 19 18 3 12 2 34
2022/2023514 61 71 42 23 43 42 14 22 170 1 19 6
2023/2024180 10 16 5 2 17 78 17 17 6 12 0 0
Totale 1.662